Business Context and Reporting Period
This Form 8-K filing by Alnylam Pharmaceuticals, Inc. reports on events occurring on February 4, 2009, with the report filed on February 6, 2009. The filing focuses on the authorization of a new 2009 Annual Incentive Program for specified employees, including executive officers.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document is a current report regarding corporate governance and compensation rather than a financial statement.
Material Changes
The primary material change is the implementation of the 2009 Annual Incentive Program. This program establishes a cash bonus structure based on individual and corporate goals. Key structural changes include:
- Target Opportunities: Bonuses are capped at a percentage of base salary, ranging from 50% for the CEO to 7% for Associate Directors.
- Performance Modifiers: A corporate performance modifier (0% to 100%) applies to individual awards. If corporate performance falls below a 50% threshold, the modifier becomes 0%.
- Payment Timing: Awards will be evaluated at the end of 2009 and paid in January 2010.
Guidance, Outlook, and Risks
The filing outlines the mechanism for determining executive compensation but does not provide financial guidance, revenue outlook, or specific risk factors beyond the inherent performance risks of the bonus plan. Management commentary is limited to the approval of corporate goals by the Board and the establishment of individual objectives for executives.
Investor Verification Checklist
- Verify the specific corporate goals approved by the Board for 2009, as these determine the corporate performance modifier.
- Confirm the base salary figures for executive officers to calculate potential maximum bonus liabilities.
- Review subsequent filings to determine if the 50% corporate performance threshold was met in 2009.
- Check for any amendments to the plan or changes in executive leadership that might alter the target opportunities.